Utilization of medication (N = 1180) | All | Poorest households | Less-poor households |  |
---|---|---|---|---|
n (%) | n (%) | n (%) | p-valuec | |
Artemether-lumefantrine | 396 (33.6) | 185 (30.9) | 211 (36.2) | 0.434 |
Sulphadoxine-pyrimethamine | 8 (0.7) | 6 (1.0) | 2 (0.3) | 0.119 |
Amodiaquine | 11 (0.9) | 7 (1.2) | 4 (0.7) | 0.284 |
Quinine | 14 (1.2) | 6 (1.0) | 8 (1.4) | 0.721 |
Chloroquine | 5 (0.4) | 3 (0.3) | 2 (0.3) | 0.557 |
Overall (any malaria medicine) | 429 (36.4) | 205 (34.3) | 224 (38.4) | 0.133 |
Non-recommended medicinea | 38 (4.2) | 22 (4.9) | 16 (3.5) | 0.332 |
 | Mean (SD) in USD | Mean (SD) in USD | Mean (SD) in USD |  |
---|---|---|---|---|
Expenditure on all malaria medications per person | 0.38 (0.50) | 0.35 (0.52) | 0. 40 (0.55) | 0.076 |
 | Mean (SD) Median (IQR) in USD | Mean (SD) Median (IQR) in USD | Mean (SD) Median (IQR) in USD | p-valued |
---|---|---|---|---|
Expenditure on all medications per person among only those who paid for drugs (n = 424)b | 1.04 (0.32) 1.01 (1.01–1.01) | 1.02 (0.32) 1.01 (1.01–1.01) | 1.05 (0.33) 1.01 (1.01–1.01) | 0.345 0.926 |
Expenditure on non-recommended malaria medicines per person (n = 38) | 1.14 (0.86) 0.62 (0.42–2.24) | 1.36 (0.91) 1.43 (0.45–2.24) | 0.98 (0.80) 0.62 (0.42–2.24) | 0.039 0.018 |